PubRank

Jason D Morrow

Author PubWeight™ 223.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Accelerated telomere shortening in response to life stress. Proc Natl Acad Sci U S A 2004 12.89
2 A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice. PLoS One 2008 3.25
3 Cellular mechanisms of redox cell signalling: role of cysteine modification in controlling antioxidant defences in response to electrophilic lipid oxidation products. Biochem J 2004 3.15
4 The relationship between dose of vitamin E and suppression of oxidative stress in humans. Free Radic Biol Med 2007 2.62
5 Quantification of F2-isoprostanes as a biomarker of oxidative stress. Nat Protoc 2007 2.56
6 Quantification of the major urinary metabolite of PGE2 by a liquid chromatographic/mass spectrometric assay: determination of cyclooxygenase-specific PGE2 synthesis in healthy humans and those with lung cancer. Anal Biochem 2004 2.24
7 Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am J Respir Crit Care Med 2002 2.17
8 Factors associated with oxidative stress in human populations. Am J Epidemiol 2002 2.13
9 Interaction of electrophilic lipid oxidation products with mitochondria in endothelial cells and formation of reactive oxygen species. Am J Physiol Heart Circ Physiol 2005 2.12
10 Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides. J Biol Chem 2002 2.11
11 Lipid peroxidation in aging brain and Alzheimer's disease. Free Radic Biol Med 2002 2.08
12 Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway. Cancer Prev Res (Phila) 2009 2.06
13 Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol 2007 1.98
14 Angiotensin II induces interleukin-6 in humans through a mineralocorticoid receptor-dependent mechanism. Hypertension 2006 1.91
15 Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. J Clin Invest 2002 1.86
16 Contribution of cyclooxygenase-2 to elevated biosynthesis of thromboxane A2 and prostacyclin in cigarette smokers. Circulation 2005 1.82
17 Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease. Ann Neurol 2002 1.79
18 Selective vulnerability of preterm white matter to oxidative damage defined by F2-isoprostanes. Ann Neurol 2005 1.77
19 Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem 2006 1.70
20 Human biochemistry of the isoprostane pathway. J Biol Chem 2008 1.63
21 Isoprostanes and related products of lipid peroxidation in neurodegenerative diseases. Chem Phys Lipids 2004 1.63
22 Cyclooxygenase-2 promotes early atherosclerotic lesion formation in LDL receptor-deficient mice. Circulation 2002 1.62
23 Prospective study of urinary prostaglandin E2 metabolite and colorectal cancer risk. J Clin Oncol 2006 1.62
24 Ibuprofen use, endotoxemia, inflammation, and plasma cytokines during ultramarathon competition. Brain Behav Immun 2006 1.54
25 Circulating neutrophils maintain physiological blood pressure by suppressing bacteria and IFNgamma-dependent iNOS expression in the vasculature of healthy mice. Blood 2008 1.53
26 Cyclooxygenase-1 is overexpressed and promotes angiogenic growth factor production in ovarian cancer. Cancer Res 2003 1.53
27 Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial. Circulation 2003 1.49
28 Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment. Ann Neurol 2005 1.49
29 Vitamin E and immunity after the Kona Triathlon World Championship. Med Sci Sports Exerc 2004 1.47
30 F2-isoprostanes as markers of oxidative stress in vivo: an overview. Biomarkers 2005 1.44
31 Neuronal oxidative damage from activated innate immunity is EP2 receptor-dependent. J Neurochem 2002 1.44
32 The isoprostanes: unique products of arachidonic acid oxidation-a review. Curr Med Chem 2003 1.44
33 Centralized oversight of physician-scientist faculty development at Vanderbilt: early outcomes. Acad Med 2008 1.42
34 Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglandin EP2 receptor. J Clin Invest 2003 1.42
35 Cyclooxygenase-1 is a potential target for prevention and treatment of ovarian epithelial cancer. Cancer Res 2005 1.36
36 The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells. Proc Natl Acad Sci U S A 2004 1.36
37 Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke: the Biomarker Evaluation for Antioxidant Therapies in Stroke (BEAT-Stroke) study. Stroke 2007 1.35
38 Fish oil increases cholesterol storage in white adipose tissue with concomitant decreases in inflammation, hepatic steatosis, and atherosclerosis in mice. J Nutr 2007 1.35
39 Lack of integrin alpha1beta1 leads to severe glomerulosclerosis after glomerular injury. Am J Pathol 2004 1.33
40 DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension 2003 1.32
41 Rescue of female infertility from the loss of cyclooxygenase-2 by compensatory up-regulation of cyclooxygenase-1 is a function of genetic makeup. J Biol Chem 2003 1.32
42 Urine PGE-M: A metabolite of prostaglandin E2 as a potential biomarker of advanced colorectal neoplasia. Clin Gastroenterol Hepatol 2006 1.32
43 Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription. PLoS One 2009 1.29
44 A phase II study of celecoxib in combination with paclitaxel, carboplatin, and radiotherapy for patients with inoperable stage IIIA/B non-small cell lung cancer. Clin Cancer Res 2009 1.27
45 Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. J Biol Chem 2008 1.26
46 Colon carcinoma cell growth is associated with prostaglandin E2/EP4 receptor-evoked ERK activation. J Biol Chem 2004 1.26
47 Formation of F-ring isoprostane-like compounds (F3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem 2006 1.25
48 Targeting cyclooxygenase-2 in recurrent non-small cell lung cancer: a phase II trial of celecoxib and docetaxel. Clin Cancer Res 2005 1.23
49 Acetylcholine-induced endothelium-dependent contractions in the SHR aorta: the Janus face of prostacyclin. Br J Pharmacol 2005 1.21
50 Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid. J Appl Physiol (1985) 2002 1.20
51 Intraindividual variability of plasma antioxidants, markers of oxidative stress, C-reactive protein, cotinine, and other biomarkers. Epidemiology 2006 1.19
52 Age-related impairment of the transcriptional responses to oxidative stress in the mouse heart. Physiol Genomics 2003 1.19
53 Relations of glycemic index and glycemic load with plasma oxidative stress markers. Am J Clin Nutr 2006 1.18
54 Expression of COX-2 in platelet-monocyte interactions occurs via combinatorial regulation involving adhesion and cytokine signaling. J Clin Invest 2006 1.18
55 A phase I trial to determine the optimal biological dose of celecoxib when combined with erlotinib in advanced non-small cell lung cancer. Clin Cancer Res 2006 1.18
56 Highly sensitive C-reactive protein, body mass index, and serum lipids in HIV-infected persons receiving antiretroviral therapy: a longitudinal study. J Acquir Immune Defic Syndr 2009 1.16
57 The effect of vitamins C and E on biomarkers of oxidative stress depends on baseline level. Free Radic Biol Med 2008 1.15
58 Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem 2008 1.15
59 Epidemiological marker for oxidant status: comparison of the ELISA and the gas chromatography/mass spectrometry assay for urine 2,3-dinor-5,6-dihydro-15-F2t-isoprostane. Ann Epidemiol 2004 1.13
60 Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta. Hypertension 2006 1.13
61 Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. J Clin Invest 2008 1.12
62 Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase. J Biol Chem 2003 1.11
63 Levels of prostaglandin E metabolite, the major urinary metabolite of prostaglandin E2, are increased in smokers. Clin Cancer Res 2005 1.10
64 RAW264.7 cells lack prostaglandin-dependent autoregulation of tumor necrosis factor-alpha secretion. J Lipid Res 2005 1.09
65 Urinary prostaglandin F2alpha is generated from the isoprostane pathway and not the cyclooxygenase in humans. J Biol Chem 2006 1.09
66 Short- and long-term COX-2 inhibition reverses endothelial dysfunction in patients with hypertension. Hypertension 2003 1.09
67 The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography. Kidney Int 2003 1.07
68 Urinary F2-isoprostanes are not associated with increased risk of type 2 diabetes. Obes Res 2005 1.07
69 Antioxidant supplementation decreases lipid peroxidation biomarker F(2)-isoprostanes in plasma of smokers. Cancer Epidemiol Biomarkers Prev 2002 1.07
70 Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer's disease. J Alzheimers Dis 2004 1.07
71 Correlation between two markers of inflammation, serum C-reactive protein and interleukin 6, and indices of oxidative stress in patients with high risk of cardiovascular disease. Biomarkers 2008 1.07
72 Quantification of F2-isoprostanes as a reliable index of oxidative stress in vivo using gas chromatography-mass spectrometry (GC-MS) method. Free Radic Biol Med 2009 1.06
73 Cyclooxygenase-2 promotes early atherosclerotic lesion formation in ApoE-deficient and C57BL/6 mice. J Mol Cell Cardiol 2005 1.06
74 Antioxidant supplementation prevents exercise-induced lipid peroxidation, but not inflammation, in ultramarathon runners. Free Radic Biol Med 2004 1.05
75 Cyclopentenone isoprostanes inhibit the inflammatory response in macrophages. J Biol Chem 2005 1.05
76 Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 2005 1.05
77 Fatty acid oxidation in the pathogenesis of Alzheimer's disease. Am J Pathol 2005 1.04
78 F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxid Redox Signal 2005 1.04
79 Cyclopentenone isoprostanes are novel bioactive products of lipid oxidation which enhance neurodegeneration. J Neurochem 2006 1.03
80 Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans. Am J Hypertens 2003 1.02
81 Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes. J Neurovirol 2002 1.02
82 Regiochemistry of neuroprostanes generated from the peroxidation of docosahexaenoic acid in vitro and in vivo. J Biol Chem 2005 1.01
83 Increased levels of F2-isoprostanes following aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med 2006 1.01
84 Cyclooxygenase-2-derived prostaglandin E(2) directs oocyte maturation by differentially influencing multiple signaling pathways. J Biol Chem 2006 1.00
85 Hypertrophic osteoarthropathy pathogenesis: a case highlighting the potential role for cyclo-oxygenase-2-derived prostaglandin E2. Nat Clin Pract Rheumatol 2006 1.00
86 Extracellular signal-regulated kinase is a target of cyclooxygenase-1-peroxisome proliferator-activated receptor-delta signaling in epithelial ovarian cancer. Cancer Res 2007 1.00
87 Development of oxidative stress by cytochrome P450 induction in rodents is selective for barbiturates and related to loss of pyridine nucleotide-dependent protective systems. J Biol Chem 2008 0.99
88 Formation of highly reactive A-ring and J-ring isoprostane-like compounds (A4/J4-neuroprostanes) in vivo from docosahexaenoic acid. J Biol Chem 2002 0.99
89 Identification of a novel class of endoperoxides from arachidonate autoxidation. J Biol Chem 2003 0.98
90 Up-regulation of the enzymes involved in prostacyclin synthesis via Ras induces vascular endothelial growth factor. Gastroenterology 2004 0.98
91 Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster. J Hypertens 2002 0.98
92 Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid. "Dioxetane" intermediate versus beta-fragmentation of peroxyl radicals. J Biol Chem 2003 0.98
93 Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms. J Immunol 2005 0.97
94 F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease. J Mol Neurosci 2007 0.97
95 Cell proliferation and apoptotic indices predict adenoma regression in a placebo-controlled trial of celecoxib in familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev 2004 0.97
96 Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation. J Neurochem 2008 0.97
97 Elevated levels of urinary prostaglandin e metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients. Cancer Prev Res (Phila) 2009 0.97
98 Lipid oxidative markers are significantly increased in lipoatrophy but not in sustained asymptomatic hyperlactatemia. J Acquir Immune Defic Syndr 2003 0.96
99 Thioredoxin-1 modulates transcription of cyclooxygenase-2 via hypoxia-inducible factor-1alpha in non-small cell lung cancer. Cancer Res 2006 0.96
100 Cyclooxygenase-1-dependent prostaglandin synthesis modulates tumor necrosis factor-alpha secretion in lipopolysaccharide-challenged murine resident peritoneal macrophages. J Biol Chem 2004 0.96
101 Oxidant stress in HIV-infected women from the Women's Interagency HIV Study. Antivir Ther 2009 0.96
102 Recent advances in the biochemistry and clinical relevance of the isoprostane pathway. Lipids 2005 0.96
103 Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness. J Virol 2004 0.96
104 Is oxidant stress a connection between obesity and atherosclerosis? Arterioscler Thromb Vasc Biol 2003 0.95
105 The cyclopentenone (A2/J2) isoprostanes--unique, highly reactive products of arachidonate peroxidation. Antioxid Redox Signal 2005 0.95
106 Quantification of F-ring isoprostane-like compounds (F4-neuroprostanes) derived from docosahexaenoic acid in vivo in humans by a stable isotope dilution mass spectrometric assay. J Chromatogr B Analyt Technol Biomed Life Sci 2004 0.95
107 Chronic quercetin ingestion and exercise-induced oxidative damage and inflammation. Appl Physiol Nutr Metab 2008 0.95
108 Dietary supplementation of omega-3 fatty acid-containing fish oil suppresses F2-isoprostanes but enhances inflammatory cytokine response in a mouse model of ovalbumin-induced allergic lung inflammation. Free Radic Biol Med 2009 0.95
109 Cyclopentenone prostaglandin, 15-deoxy-Delta12,14-PGJ2, is metabolized by HepG2 cells via conjugation with glutathione. Chem Res Toxicol 2007 0.95
110 Influence of vitamin C supplementation on oxidative and immune changes after an ultramarathon. J Appl Physiol (1985) 2002 0.94
111 Clinical factors associated with plasma F2-isoprostane levels in HIV-infected adults. HIV Clin Trials 2009 0.93
112 Isoprostanes and related compounds: update 2006. Antioxid Redox Signal 2006 0.93
113 Formation of isoprostane bicyclic endoperoxides from the autoxidation of cholesteryl arachidonate. J Am Chem Soc 2002 0.93
114 Stromal production of prostacyclin confers an antiapoptotic effect to colonic epithelial cells. Cancer Res 2003 0.93
115 Vitamin C supplementation decreases oxidative stress biomarker f2-isoprostanes in plasma of nonsmokers exposed to environmental tobacco smoke. Nutr Cancer 2003 0.93
116 Separation and identification of F2-isoprostane regioisomers and diastereomers by novel liquid chromatographic/mass spectrometric methods. J Chromatogr B Analyt Technol Biomed Life Sci 2005 0.93
117 Dietary fish oil exerts hypolipidemic effects in lean and insulin sensitizing effects in obese LDLR-/- mice. J Nutr 2009 0.93
118 Neurotoxic lipid peroxidation species formed by ischemic stroke increase injury. Free Radic Biol Med 2009 0.92
119 Identification of intact oxidation products of glycerophospholipids in vitro and in vivo using negative ion electrospray iontrap mass spectrometry. J Mass Spectrom 2009 0.92
120 Effect of alpha-tocopherol supplementation on plasma homocysteine and oxidative stress in highly trained athletes before and after exhaustive exercise. J Nutr Biochem 2005 0.92
121 The cyclopentenone product of lipid peroxidation, 15-A(2t)-isoprostane (8-isoprostaglandin A(2)), is efficiently conjugated with glutathione by human and rat glutathione transferase A4-4. Chem Res Toxicol 2002 0.92
122 Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients. Mitochondrion 2009 0.92
123 Cyclopentenone eicosanoids as mediators of neurodegeneration: a pathogenic mechanism of oxidative stress-mediated and cyclooxygenase-mediated neurotoxicity. Brain Pathol 2005 0.92
124 The cyclopentenone product of lipid peroxidation, 15-A2t-isoprostane, is efficiently metabolized by HepG2 cells via conjugation with glutathione. Chem Res Toxicol 2004 0.92
125 Associations between apolipoprotein E genotype and circulating F2-isoprostane levels in humans. Lipids 2005 0.91
126 S1P/S1P2 signaling induces cyclooxygenase-2 expression in Wilms tumor. J Urol 2009 0.91
127 Correlation of F4-neuroprostanes levels in cerebrospinal fluid with outcome of aneurysmal subarachnoid hemorrhage in humans. Free Radic Biol Med 2009 0.91
128 Cimetidine does not prevent lung injury in newborn premature infants. Pediatr Res 2006 0.91
129 Impairment of the transcriptional responses to oxidative stress in the heart of aged C57BL/6 mice. Ann N Y Acad Sci 2004 0.91
130 Brassica vegetable consumption reduces urinary F2-isoprostane levels independent of micronutrient intake. Carcinogenesis 2006 0.91
131 Essential role of the redox-sensitive kinase p66shc in determining energetic and oxidative status and cell fate in neuronal preconditioning. J Neurosci 2010 0.91
132 Identification of the major urinary metabolite of the highly reactive cyclopentenone isoprostane 15-A(2t)-isoprostane in vivo. J Biol Chem 2005 0.90
133 Allergen-induced airway hyperresponsiveness mediated by cyclooxygenase inhibition is not dependent on 5-lipoxygenase or IL-5, but is IL-13 dependent. J Immunol 2005 0.90
134 Aspirin therapy and thromboxane biosynthesis in systemic lupus erythematosus. Lupus 2007 0.89
135 Prolonged alpha-tocopherol deficiency decreases oxidative stress and unmasks alpha-tocopherol-dependent regulation of mitochondrial function in the brain. J Biol Chem 2008 0.89
136 In vivo and in vitro lipid peroxidation of arachidonate esters: the effect of fish oil omega-3 lipids on product distribution. J Am Chem Soc 2006 0.89
137 Human colorectal cancer cells efficiently conjugate the cyclopentenone prostaglandin, prostaglandin J(2), to glutathione. Biochim Biophys Acta 2002 0.89
138 Association between low serum enterolactone and increased plasma F2-isoprostanes, a measure of lipid peroxidation. Atherosclerosis 2002 0.88
139 Oncogenic potential of MEK1 in rat intestinal epithelial cells is mediated via cyclooxygenase-2. Gastroenterology 2005 0.88
140 Oral quercetin supplementation and blood oxidative capacity in response to ultramarathon competition. Int J Sport Nutr Exerc Metab 2008 0.88
141 Oxidant stress but not thromboxane decreases with epoprostenol therapy. Free Radic Biol Med 2005 0.88
142 Increased oxidative stress in patients with depression and its relationship to treatment. Psychiatry Res 2012 0.88
143 Identification of novel autoxidation products of the omega-3 fatty acid eicosapentaenoic acid in vitro and in vivo. J Biol Chem 2007 0.88
144 Lipids versus proteins as major targets of pro-oxidant, direct-acting hemolytic agents. Toxicol Sci 2005 0.87
145 In vivo oxidative damage in rats is associated with barbiturate response but not other cytochrome P450 inducers. Mol Pharmacol 2007 0.87
146 Effect of daily fruit ingestion on angiotensin converting enzyme activity, blood pressure, and oxidative stress in chronic smokers. Free Radic Res 2005 0.87
147 F2-dihomo-isoprostanes arise from free radical attack on adrenic acid. J Lipid Res 2008 0.87
148 Prostaglandin E2 is a product of induced prostaglandin-endoperoxide synthase 2 and microsomal-type prostaglandin E synthase at the implantation site of the hamster. J Biol Chem 2004 0.86
149 Inhaled nitric oxide attenuates hyperoxic lung injury in lambs. Pediatr Res 2005 0.86
150 Comparison of three oxidative stress biomarkers in a sample of healthy adults. Biomarkers 2009 0.86
151 Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease. Br J Nutr 2008 0.86
152 Antioxidants significantly affect the formation of different classes of isoprostanes and neuroprostanes in rat cerebral synaptosomes. Biochem Pharmacol 2003 0.86
153 Cyclooxygenase-1 deficiency in bone marrow cells increases early atherosclerosis in apolipoprotein E- and low-density lipoprotein receptor-null mice. Circulation 2005 0.85
154 Electrophilic cyclopentenone isoprostanes in neurodegeneration. J Mol Neurosci 2007 0.85
155 Primaquine-induced hemolytic anemia: effect of 6-methoxy-8-hydroxylaminoquinoline on rat erythrocyte sulfhydryl status, membrane lipids, cytoskeletal proteins, and morphology. J Pharmacol Exp Ther 2002 0.84
156 The fatty acid oxidation product 15-A3t-isoprostane is a potent inhibitor of NFκB transcription and macrophage transformation. J Neurochem 2011 0.84
157 Effects of vitamin E on oxidative stress and atherosclerosis in an obese hyperlipidemic mouse model. J Nutr Biochem 2006 0.84
158 PGI synthase overexpression protects against bleomycin-induced mortality and is associated with increased Nqo 1 expression. Am J Physiol Lung Cell Mol Physiol 2011 0.84
159 Acute angiotensin II increases plasma F2-isoprostanes in salt-replete human hypertensives. Free Radic Biol Med 2003 0.84
160 Primaquine-induced hemolytic anemia: role of membrane lipid peroxidation and cytoskeletal protein alterations in the hemotoxicity of 5-hydroxyprimaquine. J Pharmacol Exp Ther 2005 0.84
161 Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome. Am J Hypertens 2004 0.83
162 The enteropathy of prostaglandin deficiency. J Gastroenterol 2009 0.83
163 Oxidative stress in fibromyalgia and its relationship to symptoms. Clin Rheumatol 2008 0.83
164 Oxidant stress and peripheral neuropathy during antiretroviral therapy: an AIDS clinical trials group study. J Acquir Immune Defic Syndr 2006 0.82
165 Ibuprofen use during extreme exercise: effects on oxidative stress and PGE2. Med Sci Sports Exerc 2007 0.82
166 Markers of oxidative stress and systemic vasoconstriction in pregnant women drinking > or =48 g of alcohol per day. Alcohol Clin Exp Res 2008 0.81
167 Effect of resistance exercise and carbohydrate ingestion on oxidative stress. Free Radic Res 2005 0.81
168 Elevated oxidation of docosahexaenoic acid, 22:6 (n-3), in brain regions of rats undergoing ethanol withdrawal. Neurosci Lett 2006 0.80
169 The sterol response element binding protein regulates cyclooxygenase-2 gene expression in endothelial cells. J Lipid Res 2005 0.80
170 Nitric oxide deficiency promotes vascular side effects of cyclooxygenase inhibitors. Blood 2006 0.80
171 Restoration of on-time embryo implantation corrects the timing of parturition in cytosolic phospholipase A2 group IVA deficient mice. Biol Reprod 2009 0.79
172 Thioredoxin reductase reduces lipid hydroperoxides and spares alpha-tocopherol. Biochem Biophys Res Commun 2002 0.79
173 Sex differences in urinary biomarkers of vascular and endothelial function in HIV-infected persons receiving antiretroviral therapy. Antivir Ther 2011 0.79
174 Cyclooxygenase-2-dependent prostacyclin formation is regulated by low density lipoprotein cholesterol in vitro. Arterioscler Thromb Vasc Biol 2002 0.78
175 The antiangiogenic agent SU5416 down-regulates phorbol ester-mediated induction of cyclooxygenase 2 expression by inhibiting nicotinamide adenine dinucleotide phosphate oxidase activity. Cancer Res 2003 0.78
176 Infections due to non-neoformans cryptococcal species. Compr Ther 2003 0.78
177 Influence of carbohydrate ingestion on oxidative stress and plasma antioxidant potential following a 3 h run. Free Radic Res 2003 0.78
178 Drugs to Treat Systemic Lupus Erythematosus: Relationship between Current Use and Cardiovascular Risk Factors. Arch Drug Inf 2008 0.78
179 Formation of novel D-ring and E-ring isoprostane-like compounds (D4/E4-neuroprostanes) in vivo from docosahexaenoic acid. Adv Exp Med Biol 2002 0.77
180 Influence of carbohydrate, intense exercise, and rest intervals on hormonal and oxidative changes. Int J Sport Nutr Exerc Metab 2007 0.77
181 Quantification of F2-isoprostanes by gas chromatography/mass spectrometry as a measure of oxidant stress. Curr Protoc Toxicol 2005 0.77
182 Enzyme immunoassays for 15-F2T isoprostane-M, an urinary biomarker for oxidant stress. Adv Exp Med Biol 2002 0.77
183 20-Hydroxylation is the CYP-dependent and retinoid-inducible leukotriene B4 inactivation pathway in human and mouse skin cells. Arch Biochem Biophys 2009 0.77
184 F2-isoprostanes as markers of oxidant stress: an overview. Curr Protoc Toxicol 2005 0.77
185 p66(shc)'s role as an essential mitophagic molecule in controlling neuronal redox and energetic tone. Autophagy 2010 0.76
186 Inhibition of cyclooxygenase with indomethacin phenethylamide reduces atherosclerosis in apoE-null mice. Biochem Pharmacol 2005 0.76
187 Degree of heteroplasmy reflects oxidant damage in a large family with the mitochondrial DNA A8344G mutation. Free Radic Biol Med 2005 0.76
188 Mouse cerebral prostaglandins, but not oxidative damage, change with age and are responsive to indomethacin treatment. Brain Res 2002 0.76
189 Influence of vitamin C supplementation on oxidative and salivary IgA changes following an ultramarathon. Eur J Appl Physiol 2003 0.76
190 Long-term vitamin E deficiency in mice decreases superoxide radical production in brain. Ann N Y Acad Sci 2004 0.76
191 In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets. Blood 2005 0.75
192 Splicing mutation of the prostacyclin synthase gene in a family associated with hypertension. Adv Exp Med Biol 2003 0.75
193 Introduction for special forum issue on isoprostanes and related compounds. Antioxid Redox Signal 2005 0.75
194 Thromboxane and isoprostanes as inflammatory and vasoactive mediators in black walnut heartwood extract induced equine laminitis. Vet Immunol Immunopathol 2008 0.75
195 Age-independent, gray matter-localized, brain-enhanced oxidative stress in male fischer 344 rats: brain levels of F(2)-isoprostanes and F(4)-neuroprostanes. Free Radic Biol Med 2003 0.75
196 Pantothenic acid: an organ-specific pro-oxidant vitamin. Brain and liver neuroprostane levels in rats fed a pantothenic acid-deficient diet. Adv Exp Med Biol 2002 0.75
197 Fulminant Kaposi's sarcoma without mucocutaneous disease. AIDS 2003 0.75